[]

Find Clinical Drug Pipeline Developments & Deals for (L)-Histidine

Menu
Xls
Filters Filter
×
FILTER:
filter
Company Name
    filter

    Year

      filter

      DEALS // DEV.

        filter

        Country

          filter
          Sponsor
            filter

            Therapeutic Area

              filter

              Study Phase

                filter

                Deal Type

                  filter

                  Product Type

                    filter

                    Dosage Form

                      filter

                      Lead Product

                        filter

                        Target

                          Loading...

                          Therapeutic Area by Lead Product

                          Study Phase by Lead Product

                          Company by Lead Product

                          Top Deals by Deal Size (USD bn)

                          01

                          Dr. Franz Köhler Chemie GmbH

                          Country arrow
                          Pharmaconex
                          Not Confirmed

                          Dr. Franz Köhler Chemie GmbH

                          Country arrow
                          Pharmaconex
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Other Small Molecule

                          Upfront Cash : Inapplicable

                          August 13, 2018

                          Lead Product(s) : L-Histidine

                          Therapeutic Area : Nephrology

                          Highest Development Status : Phase III

                          Sponsor : Inapplicable

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          02

                          Marc Sakwa, MD

                          Country arrow
                          Pharmaconex
                          Not Confirmed

                          Marc Sakwa, MD

                          Country arrow
                          Pharmaconex
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Other Small Molecule

                          Upfront Cash : Inapplicable

                          September 07, 2012

                          Lead Product(s) : L-Histidine

                          Therapeutic Area : Cardiology/Vascular Diseases

                          Highest Development Status : Phase II

                          Sponsor : Essential Pharma

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          03

                          Centre Hospitalier Universitaire de Saint Etienne

                          Country arrow
                          Process Development
                          Not Confirmed

                          Centre Hospitalier Universitaire de Saint Etienne

                          Country arrow
                          Process Development
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Other Small Molecule

                          Upfront Cash : Inapplicable

                          July 25, 2011

                          Lead Product(s) : L-Histidine

                          Therapeutic Area : Cardiology/Vascular Diseases

                          Highest Development Status : Phase III

                          Sponsor : Jazz Pharmaceuticals | Association AIRE

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank